I’ve got my eye on four trends – the maturation of AI-powered drug development, fierce competition in the GLP-1 space, the ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, but growth may accelerate after 2026. Read more here.

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

Brand-name GLP-1 medications can exceed $11,000 for an annual ... margin will secure their seat at the executive leadership table. Tara Hanuscak PharmD, MS, Chief Transformation Officer, The ...

Factors associated with GLP-1 receptor analogue response: multivariable analysis The results of the multivariable analysis are displayed in table 2. No independent ... of patients who may benefit from ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...

Addressing more than 2,000 attendees representing 70 wholesaler companies, Dina Opici, president of Opici Family Distributing and chairwoman of Wine & Spirits Wholesalers of America (WSWA), delivered ...